Sepragen.com

Home | Contact Us 


Online Catalog


View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at sales@sepragen.com.



How Can We Help You?
Click here to contact us!

 



Sepragen Signs Pacific Rim Distributorship with YMC

HAYWARD, CA, November 11, 1998 - Sepragen Corporation (OTC BB: SPGNU, SPGNA, SPGNW) announced today that it has signed a distribution agreement with YMC CO. LTD. in Japan. This exclusive distribution agreement will cover all of Sepragen’s downstream processing purification products for cost effective bio-pharmaceutical production. YMC expects separation products to compliment and augment their current product lines. "This strategic alliance with YMC will result in an increased presence of our biotech product lines in Japan", said Cyrus Boomla, Asian Sales Manager at Sepragen Corporation.

Sepragen Corporation has pioneered the development of large-scale chromatography with it’s patented radial flow chromatography process which can isolate target molecules from high volume liquid raw material streams. Sepragen develops and licenses separation and purification processes using the company’s patented SuperFlo® , and Wedge® radial flow chromatography columns and QuantaSep™ computer controlled process chromatography workstations for use in the biopharmaceutical, food and beverage and waste management industries. The company also sells patented resins along with a new patented revolutionary designed process column line, VersaFlo® , for axial flow chromatography.

Return to News Archives main page



The statements in this release that relate to future events or performance, statements about growth, future regulatory clearances, levels of sales and market size and future manufacturing capacity and efficiencies are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to the development of markets for and commercial acceptance of the company's products and services, the availability of components, competitors' product introductions and other risks identified in the company's SEC filings. Actual results may differ from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.


Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2018 Sepragen Corporation. All rights reserved. (510) 475-0650